MEP of the week

Lobby organisation

Amgen Inc

Business / industry · Health & pharma · HQ: United States · Transparency Register entry

As of 9 September 2026, Amgen Inc appears in 17 declared MEP meetings (14 different MEPs), most often with European People's Party.

17
declared meetings
with current MEPs
14
MEPs met
€1.0M/yr
declared lobbying spend
self-reported to the register
3.7
lobbyists
full time equivalent

In their own words

“Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise…”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 17 declared meetings, by the meeting MEP's political group.

European People's Party741%
Socialists & Democrats635%
European Conservatives & Reformists212%
Renew Europe212%

Meetings by year

Declared meetings per calendar year, 2020–2026. Bar length is relative to its busiest year (7 in 2026).

2020
1
2021
0
2022
1
2023
0
2024
2
2025
6
2026
7

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Ingeborg ter Laak
3 meetings · EPP
Nicolás González Casares
2 meetings · S&D
Hildegard Bentele
1 meeting · EPP
Olivier Chastel
1 meeting · Renew
Mohammed Chahim
1 meeting · S&D

The 15 most recent declared meetings

DateMEPSubject
26 May 2026Ingeborg ter LaakBiotech Act
6 May 2026Nicola ZingarettiBiotech Act
29 Apr 2026Nicolás González CasaresPharmaceutical Policy EU-US Trade
28 Apr 2026Ingeborg ter LaakBiotech Act
22 Apr 2026Nicolás González CasaresBiotech - pharmaceutical side in the Biotech regulation
16 Apr 2026Wouter BekeEU Biotech Act I
14 Apr 2026Carlo CiccioliBiotech act
8 Oct 2025Hildegard BenteleBiotech
23 Sep 2025Olivier ChastelAPAs briefing session on Biotech Act
10 Sep 2025Vlad Vasile-VoiculescuMeeting CMA
16 Jul 2025Aurelijus VerygaInnovative Therapies and Public Health Challenges
22 Apr 2025Ingeborg ter LaakCritical medicines act
19 Feb 2025Angelika NieblerEU Pharma Policy
4 Nov 2024Pierre JouvetPrésentation des activités de l'AMGEN en France
23 Jan 2024Laura Ballarín CerezaPharmaceutical Package (Regulation)

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.